AML patients with high values of AIM2 and low values of CDC42BPA expression displayed the best prognosis, whereas these with low values of AIM2 and high values of CDC42BPA had the worst prognosis. The gene discussed is CDC42BPA; the disease is acute myeloid leukemia.